超声造影鉴别甲状腺结节良恶性的诊断价值:系统评价与Meta分析
该系统评价与Meta分析纳入29项队列研究、3197例患者共3521个甲状腺结节,评估超声造影鉴别良恶性的诊断准确性,以术后病理为参考标准。汇总敏感度0.86、特异度0.86、诊断比值比38.90、SROC曲线下面积0.93。作者认为超声造影有助于甲状腺良恶性病变的鉴别诊断,可作为常规超声的有用补充。
要点
- 超声造影鉴别甲状腺结节良恶性汇总敏感度0.86、特异度0.86。
- 汇总诊断比值比38.90,SROC曲线下面积0.93。
- 作者认为超声造影可作为常规超声的有用补充。
核心结论
- 该Meta分析提示超声造影有助于甲状腺良恶性病变的鉴别诊断。
- 作者认为凭借较高的敏感度、特异度和诊断优势,超声造影可作为常规超声的有用补充。
研究设计与样本
- 系统评价与Meta分析,检索PubMed、Embase、Cochrane图书馆和Web of Science数据库至2025年1月1日。
- 纳入报告超声造影鉴别甲状腺结节良恶性诊断性能、并以术后病理为参考标准的研究。
- 共纳入29项队列研究,涉及3197例患者的3521个甲状腺结节。
诊断标准与关键数值
- 超声造影鉴别甲状腺良恶性结节的汇总敏感度为0.86(95%CI 0.83-0.89)。
- 汇总特异度为0.86(95%CI 0.82-0.89)。
- 汇总阳性似然比为6.14(95%CI 4.83-7.80),阴性似然比为0.16(95%CI 0.12-0.20)。
- 汇总诊断比值比为38.90(95%CI 26.28-57.57)。
- SROC曲线下面积为0.93(95%CI 0.90-0.95)。
临床应用与阅片要点
- 作者认为超声造影可作为常规超声的有用补充,用于甲状腺良恶性病变的鉴别诊断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
This systematic review and meta-analysis aimed to evaluate the diagnostic accuracy of contrast-enhanced ultrasound (CEUS) for distinguishing between benign and malignant thyroid nodules. A search of the PubMed, Embase, Cochrane library, and Web of Science databases was conducted up to January 1, 2025. Studies that reported the diagnostic performance of CEUS for the identification of benign and malignant thyroid nodules and used postoperative pathology as the reference standard were selected. The pooled sensitivity, specificity, diagnostic odds ratio (DOR), positive likelihood ratio (PLR), and negative likelihood ratio (NLR) were calculated, and the area under the summary receiver operating characteristic (SROC) curve was used to examine the diagnostic accuracy of CEUS. In addition, subgroup and meta-regression analyses were conducted to evaluate the factors leading to heterogeneity. Overall, 29 cohort studies involving 3521 thyroid nodules from 3197 patients were identified. The pooled sensitivity, specificity, PLR, NLR, and DOR values of CEUS in differentiating benign and malignant thyroid nodules were 0.86 (95% CI, 0.83-0.89), 0.86 (95% CI, 0.82-0.89), 6.14 (95% CI 4.83-7.80), 0.16 (95% CI 0.12-0.20), and 38.90 (95% CI, 26.28-57.57), respectively. The area under the SROC curve was 0.93 (95% CI 0.90-0.95). This meta-analysis indicated that CEUS is useful for the differential diagnosis of patients with benign and malignant thyroid lesions. Owing to its high sensitivity, specificity, and diagnostic advantages, CEUS can be considered a useful supplement to conventional ultrasound.
引用
- Xu R, He Y, Xie X, et al. Diagnostic Value of Contrast-Enhanced Ultrasound for Differentiating Benign and Malignant Thyroid nodules: A Systematic Review and Meta‑Analysis. Ultrasound Med Biol. 2025. PMID: 40784818. doi:10.1016/j.ultrasmedbio.2025.07.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。